-
The low-hanging fruit discovered by the new drug
Time of Update: 2021-08-08
"Drug source analysisDrug source analysisThe main reason for the low-hanging fruit theory is that we compare the present reality with the past successes, and to a large extent ignore the many failed projects in the past, just like nostalgic for 50 years ago, we did not close the house at night but we forgot that most people had nothing at all at that time.
-
Watson Pharmaceutical Liuwei Anshen Capsules and Bumetanide for Injection Received Drug Re-registration Approval
Time of Update: 2021-08-08
Indications:(1) Edema diseases include congestive heart failure, liver cirrhosis, kidney disease (nephritis, nephropathy and various causes of acute and chronic renal failure), especially when the effect of other diuretics is not good, use this class of drugs It may still work .
-
Two drugs from a wholly-owned subsidiary of Jichuan Pharmaceutical withdrew from the provincial medical insurance catalog
Time of Update: 2021-08-08
’s main varieties of Pudilan Anti-inflammatory Oral Liquid and Ferric Protein Succinate Oral Solution will be released from the "Hebei Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drugs" on June 30, 2021.
-
The latest top 50 Indian pharmaceutical companies are here to see the sales data of 6 multinational pharmaceutical companies
Time of Update: 2021-08-08
According to Indian media reports, despite the greater impact of the epidemic, in the past year (data as of March 2021), the net profit of the top 50 pharmaceutical companies in India has increased by 31.
-
Novartis resubmitted its cholesterol-lowering drug inclisiran's application for marketing in the U.S. by transferring production
Time of Update: 2021-08-08
CompileriverIn December last year, the FDA rejected Novartis’ siRNA cholesterol-lowering drug Leqvio (inclisiran) due to the inability to complete the production site inspection on time .
Although Leqvio was rejected by the FDA in December last year, the EU market expressed its approval for the drug at almost the same time.
-
There are 1,600 new anti-cancer drugs under research and the research and development time has been reduced to 9 years. What is the trend of research and development in the next 5 years
Time of Update: 2021-08-08
Chinese companies are embarking on the world stageFrom the overall research and development situation, in 2020, the number of drug candidates in the oncology R&D pipeline is close to 3,500, an increase of 75% compared to 2015, which indicates that the unmet clinical needs in the oncology field are still large .
-
Zhengda Tianqing, Howson... grabbing 1 billion antithrombotic drugs!
Time of Update: 2021-08-08
According to data from Meinenet, in 2020, the combined sales of dabigatran etexilate capsules at the terminals of public medical institutions in China and physical pharmacies in cities in China will exceed 1 billion yuan .
-
Part of the online purchasing information of narcotic drugs announced Enhua Sufentanil Citrate Injection
Time of Update: 2021-08-08
On the 6th, Shanghai Sunshine Pharmaceutical Purchasing Network announced the online purchasing information of some narcotic drugs .
Drug information and reference purchase prices will be pushed to medical institutions through the "Shanghai Pharmaceutical Purchasing Service and Supervision Information System", which will take effect on July 8, 2021 .
-
National Standing Committee: Deployment to further promote the efficient and convenient medical insurance services
Time of Update: 2021-08-08
The meeting pointed out that safeguarding the labor security rights and interests of workers in new forms of employment is conducive to promoting flexible employment, increasing employment positions and increasing people's income .
-
Biotech, which is hitting the three-inch recharge, will be cleaned up?
Time of Update: 2021-08-08
Text | CloverLast Friday, CDE's notice of opinions on the "Clinical Value-Oriented Anti-tumor Drug Clinical Research and Development Guidelines" (hereinafter referred to as the "Guiding Principles") triggered a "big shock" and heated discussions in the pharmaceutical industry .
-
Kangzhe Pharmaceutical's Diazepam Nasal Spray Application Accepted
Time of Update: 2021-08-08
Diazepam nasal spray will effectively make up for the market gap and become a long-term and essential treatment for patients with acute recurrent epilepsy .
-
Pfizer meets its rivals again!
Time of Update: 2021-08-08
A few days ago, Shisiyao Group issued an announcement that Shijiazhuang Siyao's linezolid glucose injection was approved for production in imitation category 4, and it was deemed to have been reviewed .
-
Sinopharm's dual-target RNAi candidate STP707 gets clinical approval in the U.S.
Time of Update: 2021-08-08
Early studies have shown that knocking down the two targets of TGF-β1 and COX-2 in the tumor microenvironment can effectively induce active T cell infiltration .
-
Develop mRNA drugs!
Time of Update: 2021-08-08
Transfer from | Pharmaceutical Mission HillsOn July 5, “Near Neighbor Bio,” a cutting-edge in the mRNA field, announced that it had completed more than 10 million yuan in seed + round financing, which was exclusively completed by Yuansheng Ventures .
-
The State Food and Drug Administration revised the instructions for 4 kinds of medicines including cold-removing preparations
Time of Update: 2021-08-08
According to the announcement, according to the results of the adverse drug reaction evaluation, in order to further protect the safety of the public use of drugs, the National Medical Products Administration has decided to uniformly revise the four instructions [adverse reactions], [taboos] and [precautions] items including cold-removing preparations .
-
The 2021 version of the medical insurance catalogue is adjusted, and the price of AbbVie's AML innovative drug is reduced by 18.3% to "pave the way" for medical insurance negotiations
Time of Update: 2021-08-08
According to industry analysts, this "unexpected" initiative to cut prices reflects AbbVie's determination to quickly promote Vinekola tablets into the new round of China's medical insurance catalog, as well as its desire to accelerate the development and investment of the Chinese market .
-
Shufang Pharmaceutical and Heyu Pharmaceutical reached an exclusive development agreement for the new drug ABSK021 in Greater China
Time of Update: 2021-08-08
Recently, Shufang (Shanghai) Pharmaceutical, a subsidiary of Shufang Pharmaceutical, and Shanghai Heyu Biopharmaceutical have reached an exclusive licensing agreement to jointly develop the innovative drug ABSK021 for the application of indications in the field of rare diseases of the nervous system in the Greater China region .
-
2021ADA Hot Spots | "Insulin glargine U300" brings a number of blockbuster studies to the world!
Time of Update: 2021-08-08
This study aims to explore the efficacy and safety of insulin glargine U300 in adults with type 2 diabetes (T2DM) who have previously received traditional basal insulin therapy for poor blood sugar control in a wider area .
-
Lay off 156 people!
Time of Update: 2021-08-07
CompilationTom LeeRecently, according to a warning notice sent by GlaxoSmithKline (GSK) to the Tennessee Department of Labor and Workforce Development, the company has decided to close its manufacturing plant in Memphis, Tennessee, and 156 employees will face unemployment .
-
Disrupt the migraine market!
Time of Update: 2021-08-07
CompilenewbornAs the only drug approved by the US FDA to prevent and treat migraine at the same time, Biohaven Pharmaceuticals believes that its oral CGRP antagonist Nurtec ODT (rimegepant orally disintegrating tablet) has a very good market prospect .
